Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study in Patients With Hemoglobinopathy Who Received Autologous CD34+ Edited Hematopoietic Stem Cells

NCT07373639 is registered in ClinicalTrials.gov with Beam Therapeutics Inc. as lead sponsor.

NCT NCT07373639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07373639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study in Patients With Hemoglobinopathy Who Received Autologous CD34+ Edited Hematopoietic Stem Cells
Lead sponsor
Beam Therapeutics Inc.
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2025
Completion date
February 12, 2043
Enrollment
50 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinopathy, sickle cell disease